RS58138B1 - Implant koji sadrži fgf-18 - Google Patents

Implant koji sadrži fgf-18

Info

Publication number
RS58138B1
RS58138B1 RS20181404A RSP20181404A RS58138B1 RS 58138 B1 RS58138 B1 RS 58138B1 RS 20181404 A RS20181404 A RS 20181404A RS P20181404 A RSP20181404 A RS P20181404A RS 58138 B1 RS58138 B1 RS 58138B1
Authority
RS
Serbia
Prior art keywords
cartilage
delivery system
fgf
matrix
drug
Prior art date
Application number
RS20181404A
Other languages
English (en)
Serbian (sr)
Inventor
Christoph H Ladel
Hans Guehring
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of RS58138B1 publication Critical patent/RS58138B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
RS20181404A 2014-02-20 2015-02-20 Implant koji sadrži fgf-18 RS58138B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14000598 2014-02-20
PCT/EP2015/053645 WO2015124739A1 (en) 2014-02-20 2015-02-20 Implant comprising fgf-18
EP15706011.2A EP3107592B1 (en) 2014-02-20 2015-02-20 Implant comprising fgf-18

Publications (1)

Publication Number Publication Date
RS58138B1 true RS58138B1 (sr) 2019-02-28

Family

ID=50151086

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20181404A RS58138B1 (sr) 2014-02-20 2015-02-20 Implant koji sadrži fgf-18

Country Status (24)

Country Link
US (1) US10086112B2 (cg-RX-API-DMAC7.html)
EP (1) EP3107592B1 (cg-RX-API-DMAC7.html)
JP (1) JP6510547B2 (cg-RX-API-DMAC7.html)
KR (1) KR102421950B1 (cg-RX-API-DMAC7.html)
CN (1) CN106232154A (cg-RX-API-DMAC7.html)
AR (1) AR099556A1 (cg-RX-API-DMAC7.html)
AU (1) AU2015220785B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016018681B1 (cg-RX-API-DMAC7.html)
CA (1) CA2938796C (cg-RX-API-DMAC7.html)
DK (1) DK3107592T3 (cg-RX-API-DMAC7.html)
ES (1) ES2698117T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20181573T1 (cg-RX-API-DMAC7.html)
IL (1) IL247106B (cg-RX-API-DMAC7.html)
LT (1) LT3107592T (cg-RX-API-DMAC7.html)
MX (1) MX368946B (cg-RX-API-DMAC7.html)
NZ (1) NZ723177A (cg-RX-API-DMAC7.html)
PL (1) PL3107592T3 (cg-RX-API-DMAC7.html)
PT (1) PT3107592T (cg-RX-API-DMAC7.html)
RS (1) RS58138B1 (cg-RX-API-DMAC7.html)
RU (1) RU2700414C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201606697YA (cg-RX-API-DMAC7.html)
SI (1) SI3107592T1 (cg-RX-API-DMAC7.html)
WO (1) WO2015124739A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201605667B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2959509T1 (sl) 2013-02-14 2018-11-30 Nanopareil, Llc Polst iz elektropredenih hibridnih nanovlaken, postopek za izdelavo le-te in postopek čiščenja biomolekul
HRP20181572T1 (hr) 2014-02-20 2018-11-30 Merck Patent Gmbh Režim doziranja spoja fgf-18
EP3250925B1 (en) 2015-01-29 2019-04-10 Ares Trading S.A. Immunoassays for highly positively charged proteins
HRP20220737T1 (hr) 2017-09-29 2022-09-02 Merck Patent Gmbh Upalni biomarkeri za predviđanje odgovaranja na spoj fgf-18
US11513128B2 (en) 2017-09-29 2022-11-29 Merck Patent Gmbh Metabolic biomarkers for predicting responsiveness to FGF-18 compound
HRP20240665T1 (hr) 2018-09-10 2024-08-16 Merck Patent Gmbh Markeri korisni u strategijama obogaćivanja za liječenje osteoartritisa
CN117187255B (zh) * 2023-11-07 2024-01-30 北京大学第三医院（北京大学第三临床医学院） 编码FGF18或rhFGF18的mRNA及其在骨关节炎治疗中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0896825B1 (en) * 1997-08-14 2002-07-17 Sulzer Innotec Ag Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors
US6511958B1 (en) * 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
KR100380119B1 (ko) * 2001-04-19 2003-04-11 한국항공우주연구원 이원화된 통신속도 적응형 베이스 밴드 스위칭 위상시프트 키잉 장치
EP1273365A1 (fr) * 2001-07-06 2003-01-08 Recherche Et Developpement Du Groupe Cockerill Sambre Outils rotatifs pour le perçage en ligne de produits profiles
CA2500742C (en) * 2002-10-07 2014-02-18 Zymogenetics, Inc. Compositions of fgf-18 and hyaluronic acid for stimulating cartilage production and treating osteoarthritis
US8852240B2 (en) * 2004-10-25 2014-10-07 Kieran Murphy, Llc Methods and compositions for fostering and preserving bone growth
DK1828239T3 (da) * 2004-12-10 2011-12-19 Zymogenetics Inc FGF18-produktion i prokaryote værter
BRPI0715728A8 (pt) * 2006-08-25 2018-04-03 Ares Trading Sa tratamento de distúrbios cartilaginosos
AU2010221089A1 (en) 2009-03-05 2011-09-15 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects
US8431399B2 (en) 2010-03-02 2013-04-30 Taipei Medical University Method to restore cartilaginous phenotype of chondrocytes after cultured and expanded in vitro
US10130687B2 (en) * 2011-01-05 2018-11-20 Rhode Island Hospital Compositions and methods for the treatment of orthopedic disease or injury
JP5990720B2 (ja) * 2011-02-22 2016-09-14 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 骨再生及び／又は軟骨再生に使用するためのナノリザーバー技術
RU2698210C2 (ru) * 2013-12-24 2019-08-23 Арес Трейдинг С.А. Состав fgf-18 в альгинатных/коллагеновых гидрогелях
KR102437057B1 (ko) 2014-02-20 2022-08-26 메르크 파텐트 게엠베하 이식편 이식 및 조직 공학 절차에 있어서의 ｆｇｆ－１８
HRP20181572T1 (hr) 2014-02-20 2018-11-30 Merck Patent Gmbh Režim doziranja spoja fgf-18

Also Published As

Publication number Publication date
HRP20181573T1 (hr) 2018-11-30
AU2015220785B2 (en) 2018-07-19
KR102421950B1 (ko) 2022-07-18
CA2938796C (en) 2022-08-02
NZ723177A (en) 2021-12-24
IL247106B (en) 2020-02-27
MX368946B (es) 2019-10-22
EP3107592A1 (en) 2016-12-28
IL247106A0 (en) 2016-09-29
US20170056560A1 (en) 2017-03-02
ES2698117T3 (es) 2019-01-31
AU2015220785A1 (en) 2016-09-01
CA2938796A1 (en) 2015-08-27
SG11201606697YA (en) 2016-09-29
PL3107592T3 (pl) 2019-02-28
MX2016010874A (es) 2016-11-17
JP6510547B2 (ja) 2019-05-08
KR20160124806A (ko) 2016-10-28
BR112016018681A2 (pt) 2017-10-17
ZA201605667B (en) 2018-12-19
BR112016018681B1 (pt) 2021-01-05
LT3107592T (lt) 2018-12-10
PT3107592T (pt) 2018-12-03
RU2700414C2 (ru) 2019-09-17
DK3107592T3 (en) 2018-11-12
CN106232154A (zh) 2016-12-14
EP3107592B1 (en) 2018-08-22
RU2016137291A (ru) 2018-03-21
SI3107592T1 (sl) 2018-11-30
US10086112B2 (en) 2018-10-02
RU2016137291A3 (cg-RX-API-DMAC7.html) 2018-08-28
JP2017507145A (ja) 2017-03-16
WO2015124739A1 (en) 2015-08-27
AR099556A1 (es) 2016-08-03

Similar Documents

Publication Publication Date Title
Wong et al. Intra-articular injections of mesenchymal stem cell exosomes and hyaluronic acid improve structural and mechanical properties of repaired cartilage in a rabbit model
RS58138B1 (sr) Implant koji sadrži fgf-18
Ruvinov et al. Articular cartilage regeneration using acellular bioactive affinity-binding alginate hydrogel: A 6-month study in a mini-pig model of osteochondral defects
Kim et al. Osteochondral tissue regeneration using a bilayered composite hydrogel with modulating dual growth factor release kinetics in a rabbit model
RU2698210C2 (ru) Состав fgf-18 в альгинатных/коллагеновых гидрогелях
Lin et al. Biphasic hierarchical extracellular matrix scaffold for osteochondral defect regeneration
KR102437057B1 (ko) 이식편 이식 및 조직 공학 절차에 있어서의 ｆｇｆ－１８
JP2001516262A (ja) 骨の修復のための骨形成デバイスおよびその使用
JP2012519556A (ja) 骨軟骨欠損を治療するための血小板由来増殖因子組成物および方法
Yoon et al. Synergistic action of IL-8 and bone marrow concentrate on cartilage regeneration through upregulation of chondrogenic transcription factors
ES2369629T3 (es) Uso de op-1 para tratar defectos del cartílago.
Yang et al. Biofunctionalized structure and ingredient mimicking scaffolds achieving recruitment and chondrogenesis for staged cartilage regeneration
US11596712B2 (en) Autologous bone graft substitute composition
Hrabchak et al. Assessment of biocompatibility and initial evaluation of genipin cross-linked elastin-like polypeptides in the treatment of an osteochondral knee defect in rabbits
RS57853B1 (sr) Dozni režim fgf-18 jedinjenja
JPWO2013027854A1 (ja) 軟骨再生用組成物
KR101994177B1 (ko) Il-8 및 골수농축액의 조합을 이용한 연골 재생
HK1231784A1 (en) Implant comprising fgf-18
RU2745453C2 (ru) Комбинированная композиция, содержащая соединение fgf-18
Schurman et al. Spatial Proteomics of Cartilage and Bone in Osteoarthritic Knees via Mass Spectrometry Imaging Reveals Molecular Details of Disease Severity and Progression
Helgeland Scaffold-Based Temporomandibular Joint Cartilage Regeneration: Using Bone Marrow-Derived Mesenchymal Stem Cells
CN101098717A (zh) 用于修复骨折的补充的基质
Ruvinov et al. Spatiotemporal focal delivery of dual regenerating factors for osteochondral defect repair
Class et al. Patent application title: HYDROGEL SYSTEM COMPRISING SPATIALLY SEPARATED BIOACTIVE POLYPEPTIDES Inventors: Smadar Cohen (Beer Sheva, IL) Smadar Cohen (Beer Sheva, IL) Tali Re'Em (Tel Aviv, IL) Emil Ruvinov (Arad, IL)
Rollín et al. 485 ALTERED CHEMOTACTIC RESPONSE OF BONE MARROW MESENCHYMAL STEM CELLS TO PDGF-BB IN PATIENTS WITH OSTEOARTHRITIS